FAS position on compiling the list of vital and essential drugs

06-03-2017 | 14:15

The Federal Antimonopoly Service (FAS Russia) considered a petition of “Johnson & Johnson” Ltd. on the need to re-file a proposal to include medicinal drugs in the list of vital and essential drugs for 2018 in view of a positive decision of the Commission to include a drug with “Dimethyl fumarate” International Non-Proprietary Name in the list of vital and essential drugs for 2017

The Commission prepares a draft list of vital and essential drugs based on the outcome of the meetings on compiling lists of drugs and the minimum range of drugs. The final decision on approving the draft, particularly, including all medicines on the draft in the list of vital and essential drugs, is made by the Government of the Russian Federation.

The list of vital and essential drugs for 2017 was approved with No.2885-r Government Decree of 28.12.2016 and did not contain a drug with “Dimethyl fumarate” International Non-Proprietary Name.

Thus, the Government did not make a decision to include a drug with “Dimethyl fumarate” International Non-Proprietary Name in the list of vital and essential drugs for 2017.

FAS emphasizes that the Rules for compiling lists of medicinal drugs for medical use and the minimum range of drugs necessary for healthcare delivery do not provide for the procedures of preserving or transferring the resulting of Commission members’ voting to the next year.  

Head of FAS Department for Control over Social Sphere and Trade, Timophey Nizhegorodtsev commented: “We presume that “Johnson & Johnson” can file a new offer to include a drug with “Dimethyl fumarate” International Non-Proprietary Name in the list of vital and essential drugs for 2018in accord with the statutory procedure”.

Having considered the petition, FAS published its official position on re-filing proposals to include medicinal drugs in the list of vital and essential drugs for 2018.

 



Site Map

News & Events Press Releases Media Releases Image Library About the FAS Russia What We Do General Information Mission, Goals, Values Priority Setting Institutional Memory Stakeholders Engagement Center for Education and Methodics Our History Our Structure Powers of Head and Deputy Heads Our Ratings GCR Using our website International Cooperation Treaties & Agreements International Working Groups Working Group on Research of Competition Issues in the Market of International Telecommunications (Roaming) Meetings Working Group for Studying Competition Problems in the Pharmaceutical Sector Concept Note Meetings OECD Competition Committee OECD meetings 2013 OECD meetings 2014 OECD meetings 2015 OECD meetings 2016 OECD meetings 2017 OECD meetings 2018 FAS Annual Reports OECD-GVH RCC RCC Newsletter ICAP Council on Advertising Headquarters for Joint Investigations UNCTAD 13th session IGE UNCTAD Resolution Russian contributions 14th session IGE UNCTAD Resolution Russian contributions 15th session IGE UNCTAD 16th session IGE UNCTAD 17th session IGE UNCTAD EEU Model Law on Competition ICN BRICS WG (Markets of Social Importance) EU APEC Competition Policy and Law Group Annual meetings Projects ERRA Full Members Organizational Structure Archive Working Group on Investigating Issues on Pricing in the Oil and Oil Product Markets and Methods of their Functioning Meetings Document Library Legislation Reports & Analytics Cases & decisions Contacts Give feedback Contact us Links Authorities Worldwide